Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07708493
PHASE1

A Study to Test How BI 3034701 is Taken up and Processed by the Body in Healthy Men With Normal Weight or Overweight

Sponsor: Boehringer Ingelheim

View on ClinicalTrials.gov

Summary

The main objectives of this trial are: To assess the mass balance (total recovery of \[14C\]-radioactivity) in urine, faeces, and expired air after a single subcutaneous dose of BI 3034701 (C-14) in healthy male trial participants.

Official title: A Phase I, Open-label, Single-dose, Single-arm Trial to Investigate Metabolism and Pharmacokinetics of BI 3034701 (C-14) Administered to (Otherwise) Healthy Male Volunteers With Normal Body Weight or Overweight

Key Details

Gender

MALE

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

8

Start Date

2026-07-29

Completion Date

2026-10-14

Last Updated

2026-07-16

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

BI 3034701 (C-14)

BI 3034701 mixed with \[C-14\]BI 3034701